These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen. Ho AD; Lipp T; Ehninger G; Illiger HJ; Meyer P; Freund M; Hunstein W J Clin Oncol; 1988 Feb; 6(2):213-7. PubMed ID: 3422260 [TBL] [Abstract][Full Text] [Related]
24. A systematic overview of chemotherapy effects in acute myeloid leukaemia. Kimby E; Nygren P; Glimelius B; Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935 [TBL] [Abstract][Full Text] [Related]
25. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia. Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663 [TBL] [Abstract][Full Text] [Related]
26. Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study. Ceci A; de Terlizzi M; Colella R; Balducci D; Toma MG; Zurlo MG; Macchia P; Mancini A; Indolfi P; Locurto M Cancer; 1988 Dec; 62(12):2528-31. PubMed ID: 3056605 [TBL] [Abstract][Full Text] [Related]
27. [Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma]. Zheng W; Zhu J; Xie Y Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):875-6. PubMed ID: 19173838 [No Abstract] [Full Text] [Related]
28. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group. Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751 [TBL] [Abstract][Full Text] [Related]
29. Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study. Kirshner JJ; Anderson JR; Parker B; Barcos M; Cooper MR; Burns LJ; Peterson BA; Gottlieb AJ Cancer; 1993 Mar; 71(5):1852-6. PubMed ID: 8448749 [TBL] [Abstract][Full Text] [Related]
30. Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposide. Bow EJ; Sutherland JA; Kilpatrick MG; Williams GJ; Clinch JJ; Shore TB; Rubinger M; Schacter BA J Clin Oncol; 1996 Apr; 14(4):1345-52. PubMed ID: 8648393 [TBL] [Abstract][Full Text] [Related]
31. Successful treatment of histiocytic sarcoma and concurrent HIV infection using a combination of CHOP and antiretroviral therapy. Narita K; Noro R; Seike M; Matsumoto M; Fujita K; Matsumura J; Takahashi M; Kawamoto M; Gemma A Intern Med; 2013; 52(24):2805-9. PubMed ID: 24334590 [TBL] [Abstract][Full Text] [Related]
32. Successful autologous bone marrow transplantation in second remission of malignant histiocytosis. Cazin B; Gorin NC; Jouet JP; Laporte JP; Fenaux P; Walter MP; Najman A; Gosselin B; Bauters F Bone Marrow Transplant; 1990 Jun; 5(6):431-3. PubMed ID: 1695116 [TBL] [Abstract][Full Text] [Related]
33. High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system. Curry RC; Faivre G; Akkari L; Joyce JA; Lin O; Rosenblum M; Diamond EL; Fisher R; Omuro A Leuk Lymphoma; 2016 Aug; 57(8):1961-4. PubMed ID: 26727454 [No Abstract] [Full Text] [Related]
34. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia. Rees JK; Gray R; Hayhoe FG Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075 [No Abstract] [Full Text] [Related]
35. [Malignant histiocytosis. Clinical contribution and review of the subject]. Montalbetti L; Berini M; Nerviani M; Brambilla Pisoni G Minerva Med; 1987 Mar; 78(5):333-8. PubMed ID: 3822226 [TBL] [Abstract][Full Text] [Related]
36. Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). Zwick C; Birkmann J; Peter N; Bodenstein H; Fuchs R; Hänel M; Reiser M; Hensel M; Clemens M; Zeynalova S; Ziepert M; Pfreundschuh M; Ann Hematol; 2008 Sep; 87(9):717-26. PubMed ID: 18587579 [TBL] [Abstract][Full Text] [Related]